Division of Cardiology, Sacro Cuore Hospital, Negrar, Italy.
Diabetes Care. 2012 Feb;35(2):389-95. doi: 10.2337/dc11-1820. Epub 2011 Dec 30.
Data on cardiac function in patients with nonalcoholic fatty liver disease (NAFLD) are limited and conflicting. We assessed whether NAFLD is associated with abnormalities in cardiac function in patients with type 2 diabetes.
We studied 50 consecutive type 2 diabetic individuals without a history of ischemic heart disease, hepatic diseases, or excessive alcohol consumption, in whom NAFLD was diagnosed by ultrasonography. A tissue Doppler echocardiography with myocardial strain measurement was performed in all patients.
Thirty-two patients (64%) had NAFLD, and when compared with the other 18 patients, age, sex, BMI, waist circumference, hypertension, smoking, diabetes duration, microvascular complication status, and medication use were not significantly different. In addition, the left ventricular (LV) mass and volumes, ejection fraction, systemic vascular resistance, arterial elasticity, and compliance were also not different. NAFLD patients had lower e' (8.2 ± 1.5 vs. 9.9 ± 1.9 cm/s, P < 0.005) tissue velocity, higher E-to-e' ratio (7.90 ± 1.3 vs. 5.59 ± 1.1, P < 0.0001), a higher time constant of isovolumic relaxation (43.1 ± 10.1 vs. 33.2 ± 12.9 ms, P < 0.01), higher LV-end diastolic pressure (EDP) (16.5 ± 1.1 vs. 15.1 ± 1.0 mmHg, P < 0.0001), and higher LV EDP/end diastolic volume (0.20 ± 0.03 vs. 0.18 ± 0.02 mmHg, P < 0.05) than those without steatosis. Among the measurements of LV global longitudinal strain and strain rate, those with NAFLD also had higher E/global longitudinal diastolic strain rate during the early phase of diastole (E/SR(E)). All of these differences remained significant after adjustment for hypertension and other cardiometabolic risk factors.
Our data show that in patients with type 2 diabetes and NAFLD, even if the LV morphology and systolic function are preserved, early features of LV diastolic dysfunction may be detected.
非酒精性脂肪性肝病(NAFLD)患者心脏功能的数据有限且相互矛盾。我们评估了 2 型糖尿病患者中 NAFLD 是否与心脏功能异常有关。
我们研究了 50 例连续的 2 型糖尿病患者,这些患者没有缺血性心脏病、肝脏疾病或过量饮酒史,通过超声检查诊断为 NAFLD。所有患者均进行组织多普勒超声心动图心肌应变测量。
32 例(64%)患者存在 NAFLD,与其他 18 例患者相比,年龄、性别、BMI、腰围、高血压、吸烟、糖尿病病程、微血管并发症状态和药物使用无显著差异。此外,左心室(LV)质量和容量、射血分数、全身血管阻力、动脉弹性和顺应性也无差异。NAFLD 患者的 e'组织速度较低(8.2±1.5 vs. 9.9±1.9 cm/s,P<0.005),E/e' 比值较高(7.90±1.3 vs. 5.59±1.1,P<0.0001),等容舒张期时间常数较高(43.1±10.1 vs. 33.2±12.9 ms,P<0.01),LV 舒张末期压力(EDP)较高(16.5±1.1 vs. 15.1±1.0 mmHg,P<0.0001),LV EDP/舒张末期容积较高(0.20±0.03 vs. 0.18±0.02 mmHg,P<0.05)。在 LV 整体纵向应变和应变率的测量中,存在 NAFLD 的患者在舒张早期也具有较高的 E/整体纵向舒张应变率(E/SR(E))。所有这些差异在调整高血压和其他心血管代谢危险因素后仍然显著。
我们的数据表明,在 2 型糖尿病和 NAFLD 患者中,即使 LV 形态和收缩功能正常,也可能检测到 LV 舒张功能早期特征。